A new test has been developed that can assess the likelihood of experiencing a lupus disease flare in the following three months or 12 weeks. The aiSLE™ DX Flare Risk Index is a blood test that ...
This unique blood test uses two critical prognostic factors, pre-therapy clearance and genetics, to help guide therapeutic selection. Knowing an inflammatory bowel disease patient's likelihood of ...
SAN DIEGO, CA / ACCESS Newswire / April 29, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision-guided medicine, announces the novel Responder TNF blood test is now commercially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback